UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 389

Sortiert nach

Staphylococcus aureus, master manipulator of the human hemostatic system

Journal of thrombosis and haemostasis, 2018-03, Vol.16 (3), p.441-454

2018

Volltextzugriff (PDF)

When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2016-03, Vol.14 (3), p.623-627

2016

Volltextzugriff (PDF)

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

Journal of thrombosis and haemostasis, 2018-02, Vol.16 (2), p.209-219

2018

Volltextzugriff (PDF)

An open conformation of ADAMTS‐13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2018-02, Vol.16 (2), p.378-388

2018

Volltextzugriff (PDF)

Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases

Journal of internal medicine, 2021-03, Vol.289 (3), p.325-339

2021

Volltextzugriff (PDF)

Bacterial killing by platelets: making sense of (H)IT

Journal of thrombosis and haemostasis, 2018-06, Vol.16 (6), p.1182-1186

2018

Volltextzugriff (PDF)

Clumping factor A, von Willebrand factor‐binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall

Journal of thrombosis and haemostasis, 2017-05, Vol.15 (5), p.1009-1019

2017

Volltextzugriff (PDF)

Direct puncture versus contralateral femoral artery approach for catheter-directed thrombolysis of occluded infra-inguinal arterial bypass grafts

Clinical radiology, 2023-12, Vol.78 (12), p.e1001-e1009

2023

Volltextzugriff (PDF)

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study

Thrombosis research, 2020-01, Vol.185, p.13-19

2020

Volltextzugriff (PDF)

P09 FIBRIN DEPOSITION DUE TO STAPHYLOCOCCUS AUREUS COAGULASE ACTIVITY CONTRIBUTES TO THE PATHOGENESIS OF S. AUREUS CATHETER INFECTIONS

International journal of antimicrobial agents, 2013-05, Vol.41, p.S9-S10

2013

Volltextzugriff (PDF)

Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy

Journal of thrombosis and haemostasis, 2013-04, Vol.11 (4), p.679-685

2013

Volltextzugriff (PDF)

Age‐adjusted D‐dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm

Journal of thrombosis and haemostasis, 2018-02, Vol.16 (2), p.271-278

2018

Volltextzugriff (PDF)

Inhibition of major integrin αVβ3 reduces Staphylococcus aureus attachment to sheared human endothelial cells

Journal of thrombosis and haemostasis, 2016-12, Vol.14 (12), p.2536-2547

2016

Volltextzugriff (PDF)

Acute non-cirrhotic portal vein thrombosis : review

Acta gastro-enterologica belgica, 2018-04, Vol.81 (2), p.318-322

2018

Volltextzugriff (PDF)

A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

Trials, 2020-12, Vol.21 (1), p.1005-14, Article 1005

2020

Volltextzugriff (PDF)

The Effect of Anastomosis Time on Outcome in Recipients of Kidneys Donated After Brain Death: A Cohort Study

American journal of transplantation, 2015-11, Vol.15 (11), p.2900-2907

2015

Volltextzugriff (PDF)

Current management strategies and long‐term clinical outcomes of upper extremity venous thrombosis

Journal of thrombosis and haemostasis, 2016-05, Vol.14 (5), p.973-981

2016

Volltextzugriff (PDF)

The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders

Journal of thrombosis and haemostasis, 2015-11, Vol.13 (11), p.2087-2092

2015

Volltextzugriff (PDF)

Tranexamic acid to reduce bleeding after dental extraction in patients treated with non-vitamin K oral anticoagulants: design and rationale of the EXTRACT-NOAC trial

British journal of oral & maxillofacial surgery, 2019-12, Vol.57 (10), p.1107-1112

2019

Volltextzugriff (PDF)

The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays

International journal of laboratory hematology, 2018-08, Vol.40 (4), p.442-447

2018

Volltextzugriff (PDF)

Current management strategies and long‐term clinical outcomes of upper extremity venous thrombosis

Journal of thrombosis and haemostasis, 2016-05, Vol.14 (5), p.973-981

2016

Volltextzugriff (PDF)

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

Trials, 2020-12, Vol.21 (1), p.1033-1033, Article 1033

2020

Volltextzugriff (PDF)

Improving the diagnostic management of upper extremity deep vein thrombosis

Journal of thrombosis and haemostasis, 2017-01, Vol.15 (1), p.66-73

2017

Volltextzugriff (PDF)

Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence

Journal of thrombosis and haemostasis, 2011-12, Vol.9 (12), p.2436-2446

2011

Volltextzugriff (PDF)

Factor VIII deficiency does not protect against atherosclerosis

Journal of thrombosis and haemostasis, 2012-01, Vol.10 (1), p.30-37

2012

Volltextzugriff (PDF)

1 – 25 von 389

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(377)
Mit Volltextzugriff
(342)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Staphylococcus aureus, master manipulator of the human hemostatic system

When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

An open conformation of ADAMTS‐13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura

Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases

Bacterial killing by platelets: making sense of (H)IT

Clumping factor A, von Willebrand factor‐binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall

Direct puncture versus contralateral femoral artery approach for catheter-directed thrombolysis of occluded infra-inguinal arterial bypass grafts

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study

P09 FIBRIN DEPOSITION DUE TO STAPHYLOCOCCUS AUREUS COAGULASE ACTIVITY CONTRIBUTES TO THE PATHOGENESIS OF S. AUREUS CATHETER INFECTIONS

Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy

Age‐adjusted D‐dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm

Inhibition of major integrin αVβ3 reduces Staphylococcus aureus attachment to sheared human endothelial cells

Acute non-cirrhotic portal vein thrombosis : review

A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

The Effect of Anastomosis Time on Outcome in Recipients of Kidneys Donated After Brain Death: A Cohort Study

Current management strategies and long‐term clinical outcomes of upper extremity venous thrombosis

The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders

Tranexamic acid to reduce bleeding after dental extraction in patients treated with non-vitamin K oral anticoagulants: design and rationale of the EXTRACT-NOAC trial

The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays

Current management strategies and long‐term clinical outcomes of upper extremity venous thrombosis

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

Improving the diagnostic management of upper extremity deep vein thrombosis

Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence

Factor VIII deficiency does not protect against atherosclerosis

Suchergebnisse filtern